• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度城市人口中甲肝流行病学模式的变化:呈现出与欧洲国家相似的趋势。

The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.

作者信息

Das K, Jain A, Gupta S, Kapoor S, Gupta R K, Chakravorty A, Kar P

机构信息

Department of Medicine, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.

出版信息

Eur J Epidemiol. 2000 Jun;16(6):507-10. doi: 10.1023/a:1007628021661.

DOI:10.1023/a:1007628021661
PMID:11049092
Abstract

The present study was undertaken to determine the seroprevalence of the antibody against hepatitis A virus (IgG anti-HAV) in an urban population sample from Delhi (India) and to assess any change in the epidemiological pattern of HAV infection in this part of the world. A total of 500 healthy subjects were enrolled and divided into groups on the basis of age, sex and per capita income and evaluated for the presence of IgG anti HAV antibodies using a commercially available kit. The mean age of all the subjects was 32.6 +/- 13.2 yr. and the male:female ratio was 1.5:1. The overall prevalence of IgG anti-HAV in all subjects was 71.2% (356/500). The prevalence in subjects >35 years (92.1% [186/202]) was significantly higher than that in subjects <35 years (92.1% [186/202]) was significantly higher than in subjects <35 years (57% [170/298]). No statistically significant difference was observed between male and female subjects (71.4% [217/304] vs. 70.9% [139/196]) or between subjects belonging to middle and low socioeconomic groups (68.9% [135/196] vs. 72.7% [221/304]). These findings when compared with the results that were obtained in 1982, showed a decreasing prevalence of IgG anti-HAV, most significantly in younger age groups (16-35 years). Thus, we may conclude that the seroepidemiology of hepatitis A virus infection in urban population of India seems to be changing with seroprevalence in the younger population approaching a figure similar to that of the more developed European countries.

摘要

本研究旨在确定印度德里城市人口样本中甲型肝炎病毒抗体(IgG抗-HAV)的血清流行率,并评估世界该地区甲型肝炎病毒感染流行病学模式的任何变化。共招募了500名健康受试者,并根据年龄、性别和人均收入进行分组,使用市售试剂盒评估IgG抗-HAV抗体的存在情况。所有受试者的平均年龄为32.6±13.2岁,男女比例为1.5:1。所有受试者中IgG抗-HAV的总体流行率为71.2%(356/500)。35岁以上受试者的流行率(92.1%[186/202])显著高于35岁以下受试者(57%[170/298])。男性和女性受试者之间(71.4%[217/304]对70.9%[139/196])或社会经济地位中等和低等的受试者之间(68.9%[135/196]对72.7%[221/304])未观察到统计学显著差异。与1982年获得的结果相比,这些发现表明IgG抗-HAV的流行率在下降,在较年轻年龄组(16 - 35岁)中最为显著。因此,我们可以得出结论,印度城市人口中甲型肝炎病毒感染的血清流行病学似乎正在发生变化,年轻人群中的血清流行率接近更发达的欧洲国家。

相似文献

1
The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.印度城市人口中甲肝流行病学模式的变化:呈现出与欧洲国家相似的趋势。
Eur J Epidemiol. 2000 Jun;16(6):507-10. doi: 10.1023/a:1007628021661.
2
Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.印度海得拉巴市甲型肝炎病毒抗体的年龄相关血清流行率。
Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.
3
Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody.台湾南部甲型肝炎病毒血清流行病学的变化:很大一部分人口缺乏保护性抗体。
J Med Virol. 2001 Jun;64(2):104-8. doi: 10.1002/jmv.1024.
4
Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.德里一所医学院学生中甲型肝炎病毒感染的血清学研究及疫苗接种需求评估
Indian J Med Res. 2002 Jan;115:1-4.
5
The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand.泰国曼谷青少年甲型肝炎病毒感染血清流行病学的下降模式。
Southeast Asian J Trop Med Public Health. 1997 Mar;28(1):154-7.
6
Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.孟买甲型肝炎病毒血清流行率及甲型肝炎疫苗的免疫原性和安全性。
Indian J Gastroenterol. 1998 Jan;17(1):16-8.
7
Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.香港成年华人社区甲型肝炎和戊型肝炎感染的流行病学及其决定因素。
J Med Virol. 2004 Apr;72(4):538-44. doi: 10.1002/jmv.20040.
8
Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?在印度,是否应该为慢性肝病患者接种甲型肝炎病毒疫苗?
J Assoc Physicians India. 2004 Oct;52:785-7.
9
Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.新加坡甲型肝炎抗体(抗-HAV)的血清流行率:国家传染病中心的经验。
Singapore Med J. 1995 Feb;36(1):26-7.
10
Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.中国上海 0-30 岁人群甲型肝炎病毒抗体的血清流行率:甲型肝炎免疫接种的意义。
Epidemiol Infect. 2013 Mar;141(3):556-62. doi: 10.1017/S0950268812001161. Epub 2012 Jun 12.

引用本文的文献

1
Hepatitis A: A wake-up call!甲型肝炎:警钟!
Indian J Gastroenterol. 2025 Jun 19. doi: 10.1007/s12664-025-01803-6.
2
Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India.印度甲型肝炎减毒活疫苗及免疫实践专家共识与建议
Hum Vaccin Immunother. 2025 Dec;21(1):2447643. doi: 10.1080/21645515.2024.2447643. Epub 2025 Jan 16.
3
Age Group-Specific Assessment of Changing Seroepidemiology of Hepatitis A Virus Infection in North India.印度北部甲型肝炎病毒感染血清流行病学变化的年龄组特异性评估

本文引用的文献

1
An economic evaluation of hepatitis A vaccination in Dutch military personnel.
Mil Med. 1998 Aug;163(8):564-7.
2
The shift in prevalence of hepatitis A immunity in Flanders, Belgium.比利时弗拉芒地区甲型肝炎免疫流行情况的变化。
Acta Gastroenterol Belg. 1998 Jan-Mar;61(1):4-7.
3
Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.孟买甲型肝炎病毒血清流行率及甲型肝炎疫苗的免疫原性和安全性。
Indian J Gastroenterol. 1998 Jan;17(1):16-8.
Cureus. 2022 Oct 28;14(10):e30792. doi: 10.7759/cureus.30792. eCollection 2022 Oct.
4
Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India.在印度不断变化的流行病学背景下,慢性肝病患者对甲型肝炎预防的需求。
Hum Vaccin Immunother. 2021 May 4;17(5):1520-1529. doi: 10.1080/21645515.2020.1832408. Epub 2020 Nov 25.
5
Status of adult immunity to hepatitis A virus in healthcare workers from a tertiary care hospital in north India.印度北部一家三级医院医护人员对甲型肝炎病毒的成人免疫力状况。
Indian J Med Res. 2019 Nov;150(5):508-511. doi: 10.4103/ijmr.IJMR_787_18.
6
Suspected spread of hepatitis A virus from a restaurant among adults in rural area of the Kerala state, India.印度喀拉拉邦农村地区一起成年人疑似由餐厅传播的甲型肝炎病毒感染事件。
Epidemiol Infect. 2019 Jan;147:e210. doi: 10.1017/S0950268819000967.
7
Do medical college students living in hostel in India need hepatitis A vaccine?印度住在宿舍的医科大学生需要接种甲型肝炎疫苗吗?
Indian J Med Res. 2018 Aug;148(2):235-237. doi: 10.4103/ijmr.IJMR_636_17.
8
A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.一例由罕见的急性和慢性事件导致的慢加急性肝衰竭(ACLF)病例。
J Clin Exp Hepatol. 2018 Mar;8(1):95-97. doi: 10.1016/j.jceh.2017.08.006. Epub 2017 Sep 1.
9
Viral hepatitis in India: Armed Forces perspective.印度的病毒性肝炎:武装部队视角
Med J Armed Forces India. 2016 Jul;72(3):201-3. doi: 10.1016/j.mjafi.2016.07.004. Epub 2016 Aug 9.
10
A study of Hepatitis A and E virus seropositivity profile amongst young healthy adults in India.印度年轻健康成年人中甲型和戊型肝炎病毒血清阳性情况的研究。
Med J Armed Forces India. 2014 Jul;70(3):225-9. doi: 10.1016/j.mjafi.2014.06.016. Epub 2014 Jul 16.
4
The changing epidemiological pattern of hepatitis A in Lisbon, Portugal.
Eur J Gastroenterol Hepatol. 1997 Aug;9(8):795-7. doi: 10.1097/00042737-199708000-00011.
5
Pattern of hepatitis A and hepatitis B virus markers in cases of acute sporadic hepatitis and in healthy school children from north west India.印度西北部急性散发性肝炎病例及健康学童中甲肝和乙肝病毒标志物模式
J Trop Pediatr. 1995 Dec;41(6):328-9. doi: 10.1093/tropej/41.6.328.
6
Falling incidence and prevalence of hepatitis A in northern Spain.
Scand J Infect Dis. 1994;26(2):133-6. doi: 10.3109/00365549409011775.
7
The value of immunization against hepatitis A.甲型肝炎免疫接种的价值。
Infect Agents Dis. 1994 Feb;3(1):38-49.
8
Will hepatitis A become a vaccine-preventable disease?
Ann Intern Med. 1995 Mar 15;122(6):464-5. doi: 10.7326/0003-4819-122-6-199503150-00011.
9
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.1982年和1992年印度浦那甲型和戊型肝炎病毒抗体的年龄特异性流行率。
J Infect Dis. 1995 Feb;171(2):447-50. doi: 10.1093/infdis/171.2.447.
10
Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community.
Scand J Infect Dis. 1980;12(3):171-4. doi: 10.3109/inf.1980.12.issue-3.03.